Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

Clinical trial NCT06091748 · COMPLETED

Trial details

NCT number: NCT06091748
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Start date: 2024-02-22
Primary completion: 2025-11-27
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.